4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Caribou Biosciences, Inc. (CRBU) operates in the Biotechnology industry and is headquartered in Berkeley, United States with about 97 employees. Its market capitalization is roughly $172 million. In the fiscal year ended 2025-12-31, CRBU reported $11M in revenue and ($148M) in net income.
Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company.
Interactive charts & full statements → Open the CRBU valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $11M | $10M | $34M | $14M | — |
| Operating Income (EBIT) | ($136M) | ($167M) | ($116M) | ($106M) | — |
| Net Income | ($148M) | ($149M) | ($102M) | ($99M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $4M | $2M | $3M | $2M |
| Operating Income (EBIT) | ($26M) | ($28M) | ($29M) | ($35M) | ($43M) |
| Net Income | ($25M) | ($26M) | ($28M) | ($54M) | ($40M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $175M | $313M | $432M | $374M | — |
| Total Liabilities | $53M | $60M | $64M | $73M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CRBU viewer.
About TickerBase · Data methodology & sources